Magazine: Are European biopharma manufacturers ‘nearshoring’?
Is 'nearshoring', the preference among pharma and biotech to move operations to the domestic markets versus outsourcing abroad, becoming the norm?
Is 'nearshoring', the preference among pharma and biotech to move operations to the domestic markets versus outsourcing abroad, becoming the norm?
What's Your Reaction?
